Atlas Trials

The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

Clinical trial NCT04751071 · WITHDRAWN

Trial details

NCT number
NCT04751071
Sponsor
Sadat City University
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2021-02-01
Primary completion
2024-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.